mebendazole has been researched along with Lymphatic Diseases in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Lymphatic Diseases: Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flubendazole, an injectable benzimidazole drug, was compared with diethylcarbamazine (DEC) in a prospective double-blind study of the treatment of onchocerciasis." | 9.05 | Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. ( Beltran-Hernandez, F; Dominguez-Vazquez, A; Greene, BM; Murphy, RP; Rivas-Alcala, AR; Ruvalcaba-Macias, AM; Taylor, HR, 1983) |
| "Flubendazole, an injectable benzimidazole drug, was compared with diethylcarbamazine (DEC) in a prospective double-blind study of the treatment of onchocerciasis." | 5.05 | Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. ( Beltran-Hernandez, F; Dominguez-Vazquez, A; Greene, BM; Murphy, RP; Rivas-Alcala, AR; Ruvalcaba-Macias, AM; Taylor, HR, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dominguez-Vazquez, A | 1 |
| Taylor, HR | 1 |
| Greene, BM | 1 |
| Ruvalcaba-Macias, AM | 1 |
| Rivas-Alcala, AR | 1 |
| Murphy, RP | 1 |
| Beltran-Hernandez, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single Dose Treatment With Diethylcarbamazine, Albendazole and Ivermectin in Humans With and Without Wuchereria Bancrofti Infection in Côte d'Ivoire[NCT02845713] | Phase 1 | 66 participants (Actual) | Interventional | 2016-04-17 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for mebendazole and Lymphatic Diseases
| Article | Year |
|---|---|
Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis.
Topics: Adolescent; Adult; Antinematodal Agents; Benzimidazoles; Child; Clinical Trials as Topic; Diethylcar | 1983 |